Goldman Sachs Trims PT on Hologic (HOLX) After Q1, Keeps 'Buy'
Tweet Send to a Friend
Goldman Sachs trimmed its price target on Hologic (NASDAQ: HOLX) from $25 to $24 following in-line Q1 results and below-consensus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
